Anti-Factor VIII [EL-14]
AB04011-30.11-BT
ApplicationsFunctional Assay, ImmunoPrecipitation, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetF8
Overview
- SupplierAbsolute Antibody
- Product NameAnti-Factor VIII [EL-14]
- Delivery Days Customer9
- Antibody SpecificityThis antibody binds the C2 domain of the human factor VIII, a glycoprotein involved in blood coagulation. Factor VIII acts as a cofactor for factor IXa which converts factor X to the activated form Xa in the presence of calcium and phospholipids. Defects
- Application Supplier NoteThe binding characterization of this antibody towards radiolabeled FVIII light chain and the C2 domain of factor VIII was done using immunoprecipitation. The inhibitory activity of this antibody against factor VIII was determined using a one-stage clotting assay. This antibody was capable of completely eliminating FVIII inhibition by CLB-CAg 117, a C2 domain directed anti-factor VIII antibody (PMID: 10627462). The scFv version of this antibody bound factor VIII light chain with a dissociation constant of Kd = 1.1 nM (PMID: 11929772).
- ApplicationsFunctional Assay, ImmunoPrecipitation, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDEL-14
- Gene ID2157
- Target nameF8
- Target descriptioncoagulation factor VIII
- Target synonymsAHF; antihemophilic factor; coagulation factor VIII; coagulation factor VIII A1 domain; coagulation factor VIII C2 domain; coagulation factor VIII, procoagulant component; coagulation factor VIIIc; DXS1253E; F8B; F8C; factor VIII F8B; FVIII; HEMA
- Protein IDP00451
- Protein NameCoagulation factor VIII
- Scientific DescriptionThis is a reformatted human scFv antibody, based on the original human scFv format, created for improved compatibility with existing reagents, assays and techniques.
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203